The World Health Organization (WHO) is developing a toolkit to help programs implement MMDP services. The toolkit incorporates relevant resources developed by WHO and partner institutions, and its objectives are as follows:
provide tools and templates for implementation of key activities to strengthen delivery by the health system of the recommended minimum package of care for LF patients
make information and tools accessible to national LF programs and health professionals around the world
identify and resolve gaps in resources
Components focus on the following areas:
Planning, including patient estimation
Capacity Building to Deliver MMDP Services
Documentation of MMDP services
This tool (click map below for interactive map) allows the user to selectively view multiple variables at once, identifying co-endemicity and intervention gaps, and thereby provides a stepping stone for integrated programming in country.
The TAS-STH Survey Sample Builder tool was designed to help capture the impact of lymphatic filariasis programs on soil-transmitted helminthiasis and provide guidance on whether ongoing mass drug administration is needed to control the transmission of intestinal worms.
The Preventive Chemotherapy (PC) Data Portal provides access to data from the WHO’s PCT Databank for 4 key indicators (Population Requiring Preventive Chemotherapy (PCT), Population Receiving PCT, Coverage, and Comparative Performance) across the 5 PCT NTDs (Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Soil-Transmitted Helminths, and Trachoma).
The PCT Databank presents historical data as reported to WHO. This tool is designed to empower users to leverage their familiarity with Excel and the simplicity of the Global Health Observatory (GHO) to rapidly construct summaries that can be shared as they are viewed.
The Survey Sample Builder is a tool designed to help program managers with their Transmission Assessment Surveys. The SSB program can be used to automate the calculations for determining appropriate survey strategy.
Common diagnostic tools and methods used to “map” disease (determine which populations need treatment and other public health interventions to reduce transmission) and conduct ongoing disease surveillance.